BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Lynk Pharmaceuticals Doses First Patient in Phase II Trial of Novel Vitiligo Therapy

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, ...

July 10, 2026 | News

India's Garware Fulflex Acquires U.S. Medical Manufacturing Facility to Accelerate Global Expansion

Garware Fulflex today announced the successful completion of its acquisition of a 300,000-square-foot, fully automated medical products manufacturing facil...

July 10, 2026 | News

Abcam and EpiCypher Partner to Advance High-Confidence Epigenomics Research

Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC...

July 10, 2026 | News

APAC's Peptide-Capacity Gamble

For most of pharmaceutical history, the hard part was finding a molecule that worked. The GLP-1 class inverted that logic. The science arrived first &mdash...

July 09, 2026 | Analysis

Insilico Medicine Advances AI-Discovered IPF Drug Rentosertib into Phase III Trial

Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-...

July 09, 2026 | News

After the Rush: APAC's mRNA and Vaccine Capacity Hangover

In June 2022, South Korea had something it had wanted for two years: a COVID-19 vaccine of its own. SKYCovione, developed by SK bioscience with the U...

July 08, 2026 | Analysis

Matica Bio Partners with VaxDome to Advance Novel Intranasal Antiviral Vaccine Platform into Clinical Trials

Matica Biotechnology, Inc. ("Matica Bio"), a viral vector contract development and manufacturing organization (CDMO), is partnering with Texas-based biotec...

July 08, 2026 | News

J-Pharma Advances First-in-Class LAT1 Inhibitor Nanvuranlat into Global Phase 3 Trial for Biliary Tract Cancer

Pharma Co., Ltd., a clinical-stage biotechnology company focused on novel therapies targeting amino acid transporters, and Uniphar, a leading international...

July 08, 2026 | News

Arima Genomics Partners with Active Motif to Expand Global Access to Hi-C Research Portfolio

Agreement Part of Arima’s Long-Term Strategy to Focus on Core Diagnostic Platform and Tests Arima Genomics, Inc., a cancer diagnostics com...

July 07, 2026 | News

Sofinnova-Backed Myricx Bio to Join Novartis in Up to $1.5 Billion ADC Deal

Sofinnova Partners co-led the seed investment in 2019 and has supported the company from founding through to exit The proposed acquisition combines th...

July 07, 2026 | News

Takeda Partners with Insilico Medicine in Up to $600M AI Drug Discovery Collaboration

Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic areas Insilico Medicine ("Insilico" HKEX:3696),...

July 03, 2026 | News

Inductive Bio Brings AI-Powered ADMET Prediction Models to Claude via New MCP Connector

Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, announced that it has joined Anthropic’s life sciences ecosystem and l...

July 02, 2026 | News

PharmaResearch Expands U.S. Footprint with CG USA Acquisition to Boost REJURAN Cosmetics Growth

Acquisition strengthens local manufacturing and logistics capabilities as REJURAN Cosmetics expands across Sephora, Amazon and Canada, ...

July 01, 2026 | News

Can APAC Build Radioligand Therapy Before the Atoms Decay?

Every dose of radioligand therapy is a countdown. The moment a batch of lutetium-177 leaves the reactor, it begins to fade — roughly half its therape...

July 02, 2026 | Analysis

Stay Connected